This improvement allowed for better Ku-DBis assessment in cell culture conditions, where a potent single-agent activity in an ATM-deficient NSCLC cell line was observed, and a differential interaction of the Ku-DBi with DSB-inducing agents as a function of BRCA1 status was discovered. This evidence concerns the gene ATM and non-small cell lung carcinoma.